Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurosci Res ; 42(2): 207-19, 1995 Oct 01.
Article in English | MEDLINE | ID: mdl-8568921

ABSTRACT

The effects of a series of protein kinase inhibitors on nerve growth factor (NGF)-dependent and NGF-independent neurite outgrowth in PC12 cells have established an ordered relationship among those protein kinases sensitive to down regulation by bryostatin, stimulation by staurosporine, inhibition by sphingosine, or inhibition by 6-thioguanine (6-TG). Quantitation of the biphasic staurosporine effects on NGF-induced neurite outgrowth (Hashimoto and Hagino: J Neurochem 53:1675-1685, 1989) gave an IC50 of 2-4 nM for inhibition and an EC50 of 15-20 nM for induction of neurite extension. Both sphingosine and 6-TG inhibited neurite outgrowth induced by staurosporine and basic fibroblast derived growth factor (bFGF), as well as by NGF; therefore, sphingosine- and 6-TG-sensitive protein kinase steps occur after the convergence of the NGF, bFGF, and staurosporine signal pathways. Down regulation of protein kinase C by bryostatin chronic treatment, which inhibits NGF- and bFGF-induced neuritogenesis (Singh et al.: Biochemistry 33:542-551, 1994), did not inhibit the staurosporine-induced neurite outgrowth. Thus, the bryostatin-sensitive protein kinase C must occur subsequent to the convergence of the bFGF and NGF pathways, but before (or parallel to) staurosporine initiation of neurite outgrowth. In contrast, low concentrations of phorbol myristoyl acetate (PMA) or bryostatin, which activate protein kinase C activity, enhanced the staurosporine- or NGF-induced neurite extension. These data indicate that stimulation of one or more protein kinase C isozymes can synergistically interact with the signaling pathway to increase the rate of neuritogenesis. Inhibition by 5-7.5 nM staurosporine acted rapidly to arrest and decrease development of neurites up to 24 hr after NGF treatment, as did K252a and NGF polyclonal antibody addition. Our cellular data support the concept that staurosporine acts to inhibit the NGF receptor Trk (Nye et al.: Mol Biol Cell 3:677-686, 1992), but that downstream steps can be activated by the higher concentration of staurosporine to bypass Trk and lead to neurite generation. Effects of staurosporine, 6-TG, and sphingosine on c-fos gene induction with or without NGF were not correlated with the generation of neurites. The sequence of protein kinases sensitive to these effectors appears to be in the order (but not consecutive) bryostatin, staurosporine, sphingosine, and 6-TG.


Subject(s)
Enzyme Inhibitors/pharmacology , Nerve Growth Factors/physiology , Nerve Tissue Proteins/physiology , PC12 Cells/cytology , Protein Kinases/physiology , Signal Transduction/physiology , Alkaloids/pharmacology , Animals , Bryostatins , Carbazoles/pharmacology , Cell Differentiation/drug effects , Fibroblast Growth Factor 2/pharmacology , Indole Alkaloids , Lactones/pharmacology , Macrolides , Models, Biological , Neoplasm Proteins/antagonists & inhibitors , Neoplasm Proteins/physiology , Nerve Growth Factors/pharmacology , Nerve Tissue Proteins/antagonists & inhibitors , Neurites/drug effects , Neurites/ultrastructure , Neurons/cytology , Neurons/drug effects , PC12 Cells/drug effects , PC12 Cells/enzymology , Protein Kinase Inhibitors , Proto-Oncogene Proteins c-fos/biosynthesis , Proto-Oncogene Proteins c-fos/genetics , Proto-Oncogene Proteins p21(ras)/physiology , Rats , Signal Transduction/drug effects , Sphingosine/pharmacology , Staurosporine , Tetradecanoylphorbol Acetate/pharmacology , Thioguanine/pharmacology
2.
Biochemistry ; 33(2): 542-51, 1994 Jan 18.
Article in English | MEDLINE | ID: mdl-8286384

ABSTRACT

Nerve growth factor (NGF) stimulates rat pheochromocytoma cells (PC12) to differentiate into a neuronal-like cell that exhibits neurite extensions. The role of protein kinase C in signal transduction has been examined in PC12 cells treated with phorbol 12-myristate 13-acetate (PMA) and bryostatin, a macrocyclic lactone that activates protein kinase C at both the nuclear and the plasma membranes [Hocevar, B. A., & Fields, A. P. (1991) J. Biol. Chem. 266, 28-33]. In contrast to PMA down-regulation [Reinhold, D. S., & Neet, K. E. (1989) J. Biol. Chem. 264, 3538-3544], chronic (24 h) treatment with bryostatin blocked the formation of neurites in response to NGF or basic fibroblast-derived growth factor stimulation, but, like PMA, bryostatin did not block the induction of c-fos or c-jun protooncogenes by NGF. Chronic bryostatin treatment down-regulated protein kinase C activity in the cytosolic, membrane, and nuclear fractions. Acute (60 min) bryostatin or NGF treatment activated cytosolic and nuclear protein kinase C activity, suggesting possible translocation to the nucleus. Bryostatin did not induce neurite outgrowth, either alone or in combination with PMA. Thus, the bryostatin-sensitive protein kinase C is distinct from PMA- or K252a-sensitive kinases previously described. The bryostatin-sensitive protein kinase C is necessary, but not sufficient, for neurite outgrowth and acts in the nucleus in a manner independent of c-fos and c-jun transcription.


Subject(s)
Lactones/pharmacology , Nerve Growth Factors/pharmacology , Protein Kinase C/metabolism , Animals , Bryostatins , Cell Differentiation/drug effects , Enzyme Activation/drug effects , Genes, fos , Genes, jun , Kinetics , Macrolides , Neurites/physiology , Neurons/ultrastructure , PC12 Cells , RNA, Messenger/metabolism , Signal Transduction , Sphingosine/pharmacology , Tetradecanoylphorbol Acetate/pharmacology , Transcription, Genetic/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...